No you are assuming they are trying to make money. They are not trying to make money shorting the stock but want to keep the purchase price for the company as low as possible. The purchase price will be based on stock appreciation after news is announced which if DCVAX proves to be a highly effective treatment without the adverse effects of chemo for GBM and potentially all other solid tumor cancers with DCVAX-Direct with be 10X maybe even 100X what it is now. They are trying to minimize the appreciation of the stock when good news is announced. They have been working at this for the last few year and ideally would have liked to bankrupt NWBO by now so they could steal their technology for bargain basement prices. They probably realize by now that that is unlikely to happen so they are working to drive the price as low as possible in a effort (perhaps futile effort) to minimize the appreciation upon great top line results followed by approval.
News 
Market Data 
Discover 
